Constitutive activity of the metabotropic glutamate receptor 2 explored with a whole-cell label-free biosensor

Affordable Access

Download Read

Constitutive activity of the metabotropic glutamate receptor 2 explored with a whole-cell label-free biosensor

Authors
  • Doornbos, Maarten L.J.
  • Van der Linden, Ilse
  • Vereyken, Liesbeth
  • Tresadern, Gary
  • IJzerman, Adriaan P.
  • Lavreysen, Hilde
  • Heitman, Laura H.
Type
Published Article
Journal
Biochemical Pharmacology
Publisher
Elsevier
Publication Date
Jun 27, 2018
Volume
152
Pages
201–210
Identifiers
DOI: 10.1016/j.bcp.2018.03.026
Source
MyScienceWork
License
Green

Abstract

Label-free cellular assays using a biosensor provide new opportunities for studying G protein-coupled receptor (GPCR) signaling. As opposed to conventional in vitro assays, integrated receptor-mediated cellular responses are determined in real-time rather than a single downstream signaling pathway. In this study, we examined the potential of a label-free whole cell impedance-based biosensor system (i.e. xCELLigence) to study the pharma-cology of one GPCR in particular, the mGlu 2 receptor. This receptor is a target for the treatment of several psychiatric diseases such as schizophrenia and depression. After optimization of assay conditions to prevent interference of endogenous glutamate in the culture medium, detailed pharmacological assessments were performed. Concentration-response curves showed a concentration-dependent increase in impedance for agonists and positive allosteric modulators, whereas receptor inhibition by an antagonist or negative allosteric modulator resulted in a concentration-dependent decrease in cellular impedance. Interestingly, constitutive receptor activity was observed that was decreased by LY341495, which therefore behaved as an inverse agonist here, a property that was heretofore unappreciated. This was confirmed by concentration-dependent modulation of LY341495 potency and efficacy by a allosteric modulators. In summary, the use of the xCELLigence system to study mGlu 2 receptor pharmacology was validated. This is the first class C GPCR to be characterized extensively by such method, opening new avenues to study receptor pharmacology including inverse agonism and demonstrating its value for future drug discovery efforts of mGlu receptors as well as other GPCRs.

Report this publication

Statistics

Seen <100 times
Downloaded <100 times